Cargando…

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database

OBJECTIVE: The primary objective was to estimate the national prevalence of psoriasis and palmoplantar pustulosis (PPP) in Japan. Secondary objectives were to determine (1) whether psoriasis and PPP disease activity varies by season, and (2) whether disease severity is associated with concurrent dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Kiyoshi, Kamijima, Yukari, Sato, Tsugumichi, Ooba, Nobuhiro, Koide, Daisuke, Iizuka, Hajime, Nakagawa, Hidemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298108/ https://www.ncbi.nlm.nih.gov/pubmed/25588781 http://dx.doi.org/10.1136/bmjopen-2014-006450

Ejemplares similares

The use of anticoagulants in patients with non-valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan
por: Kubota, Kiyoshi, et al.
Publicado: (2018)

Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications
por: Ooba, Nobuhiro, et al.
Publicado: (2013)

Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
por: Spencer, Riley K., et al.
Publicado: (2023)

The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review
por: Sanchez, Isabelle M., et al.
Publicado: (2017)

Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Recent advances in palmoplantar pustulosis
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2021)

Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
por: Yamamoto, Toshiyuki
Publicado: (2021)

Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening
por: Ooba, Nobuhiro, et al.
Publicado: (2017)

Palmoplantar pustulosis and IgA nephropathy
por: Shimamura, Yoshinosuke, et al.
Publicado: (2018)

Palmoplantar Pustulosis: A Case Report
por: Dulski, Anne, et al.
Publicado: (2020)

Palmoplantar Pustulosis associated with Membranous Glomerulonephritis
por: Thakur, Vishal, et al.
Publicado: (2021)

Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
por: Chu, Yuqi, et al.
Publicado: (2022)

CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis
por: Reolid, Alejandra, et al.
Publicado: (2022)

The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases
por: Ramcharran, Darmendra, et al.
Publicado: (2023)

Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

A Case of Relapsing Polychondritis with Palmoplantar Pustulosis
por: Kwon, Won Joo, et al.
Publicado: (2016)

Skin-directed radiation therapy for palmoplantar pustulosis
por: King, Brian J., et al.
Publicado: (2019)

Successful Treatment of Recalcitrant Palmoplantar Pustulosis with Guselkumab
por: Jung, Jang Hwan, et al.
Publicado: (2023)

Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study
por: Miyazaki, Celine, et al.
Publicado: (2020)

Design and implementation of an adaptive confirmatory trial in Japanese patients with palmoplantar pustulosis
por: Zheng, Richuan, et al.
Publicado: (2022)

Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial
por: Terui, Tadashi, et al.
Publicado: (2019)

Combination biologic therapy for the treatment of severe palmoplantar pustulosis
por: Torre, Kristin M., et al.
Publicado: (2017)

Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
por: Misiak-Galazka, Magdalena, et al.
Publicado: (2020)

Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis
por: Benzian-Olsson, Natashia, et al.
Publicado: (2020)

Clinical characteristics and associations of palmoplantar pustulosis: an observational study()()
por: Oktem, Ayse, et al.
Publicado: (2020)

Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
por: Marovt, Maruška, et al.
Publicado: (2021)

Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination
por: Katsuie, Shiho, et al.
Publicado: (2022)

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases
por: Mössner, Rotraut, et al.
Publicado: (2008)

Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
por: Shibata, Tomoyuki, et al.
Publicado: (2019)

Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study
por: Kato, Noriko, et al.
Publicado: (2021)

Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
por: Heidemeyer, Kristine, et al.
Publicado: (2023)

Prevalence of Therapeutic Drug Monitoring for Lithium and the Impact of Regulatory Warnings: Analysis Using Japanese Claims Database
por: Ooba, Nobuhiro, et al.
Publicado: (2018)

Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab
por: Gkalpakiotis, Spyridon, et al.
Publicado: (2022)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis
por: Seol, Jung Eun, et al.
Publicado: (2016)

Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis
por: Koumaki, Dimitra, et al.
Publicado: (2019)

Improvement of palmoplantar pustulosis after excision of polyacrylamide injected into the nasal region
por: Kashiyama, Kazuya, et al.
Publicado: (2021)

SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab
por: Yang, Qingyun, et al.
Publicado: (2022)

Involvement of Molecular Mechanisms between T/B Cells and IL-23: From Palmoplantar Pustulosis to Autoimmune Diseases
por: Fukasawa, Takemichi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j56gn6q5me8lunqfjfivu7b9ld